WEBBER ROBERT J has a total of 13 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and electrical machinery and energy are SILER-KHODR THERESA M, CANCER ADVANCES INC and ST VINCENTS INSTITUTE OF MEDICAL RES.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Canada | 1 | |
#5 | United Kingdom | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Electrical machinery and energy | |
#4 | Measurement | |
#5 | Foods and drinks | |
#6 | Consumer goods |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Magnets and transformers | |
#5 | Analysing materials | |
#6 | Enzymes | |
#7 | Ice-boxes |
# | Name | Total Patents |
---|---|---|
#1 | Webber Robert J | 12 |
#2 | Webber Douglas S | 10 |
#3 | Dixon Thelma H | 5 |
#4 | Delmas Jean | 1 |
Publication | Filing date | Title |
---|---|---|
GB201318601D0 | Superior french lime filler | |
US2012096873A1 | Cryogenic system with rapid thermal cycling | |
WO2007058970A2 | RECEPTOR ANTAGONIST AS THERAPEUTIC AGENTS FOR iNOS GENERATING ILLNESS | |
US2007269442A1 | Chimeric monoclonal antibody recognizing iNOS | |
US2007105780A1 | Therapeutic agent for iNOS generating illness | |
US2007042003A1 | Method of effecting a mammalian model of sepsis, severe sepsis, or septic shock | |
CA2566651A1 | Improved therapeutic agent for inos generating illness | |
US2005260190A1 | Therapeutic agent for iNOS generating illness |